Abstract
Conversion of chromane-6-triflate 5 to chromane-6-dehydroalanine 9 or 10 via its Bpin-derivative 6 followed by Suzuki coupling with protected dehydroalanine bromides 7 or 8 were reported (86%). Alternatively, a palladium-catalyzed stannation of 5 with Bu6Sn2 afforded the tributyltin derivative 11, and iodination (12) followed by coupling with 13 gave chromane-6-alanine 15 (75%). Either approach constitutes a conversion from chromane-6-triflate to the corresponding protected chromane-6-alanine or its dehydro analog.
Keywords: Palladium-catalyzed coupling, Boronation, Stannylation, Aryl Triflate, Suzuki coupling
In connection with a synthetic project, we were interested in synthetic access to electron-rich phenylalanine derivative 4 or their potential dehydro precursors 3 from phenols 1 or triflates 2. A structure-based search of electronic databases returned several options for relevant transformations starting from phenols, and interestingly literature also reported palladium-catalyzed coupling to build the key Ar-C bond. However, in each case, the outcome raised questions regarding overall yield or number of steps.1–4 On the other hand, most of these reports involved investigations where rapid access to the targets using reliable methods was probably the primary consideration. We were therefore encouraged to evaluate alternative routes from 1 to 3 or 4 that might improve overall efficiency, and that would provide a vehicle for expanding structure-based retrieval of the simple synthetic transform from 1 to 3 or 4 (Scheme 1).
Scheme 1.
Suzuki coupling to dehydroamino acid derivatives
The known triflate 55 was chosen as a precursor to demonstrate a Suzuki coupling approach6 via the corresponding pinacolboronate 6, available in 96% yield from 5 using palladium-catalyzed boronation with bis(pinacolato)diboron, [pinB]2, following literature analogies.7,8 Suzuki coupling of 6 with the known halogenated N-Boc dehydroamino acid derivative 79 or the derived N-bis-Boc analogue 8 was then conducted in the expectation that coupling efficiency would be high in the typically well-behaved sp2-sp2 mode. Indeed, good yields of both 9 and 10 were obtained under these conditions (Scheme 1).6 The Z-geometry assigned to 9 was confirmed by a NOESY experiment, consistent with the previously established Z-geometry of 7.9a,c,10 In principle, enantioselective hydrogenation of 9 or 10 and analogous structures is possible using well known, high-yielding methods, and would provide access to either absolute configuration if desired.11 The conversion from 5 to 9 or 10 constitutes a synthetic transform from triflates to dehydroamino acid derivatives.
An alternative version of the transform from chromane-6-triflate to a chromane-6-alanine was investigated via conversion to an intermediate aryl iodide (Scheme 2). First, the chromane-6-triflate 5 was reacted with hexabutyldistannane in the presence of Pd(Ph3P)4/LiCl (dioxane, 90 °C, 12h) provided intermediate tributyltin derivative 11 according to NMR assay of the crude product.12 Filtration over alumina and removal of unreacted hexabutyldistannane under vacuum gave 11, but material recovery was modest (46%) and attempted purification by chromatography over silica gel resulted in extensive protodestannylation due to the electron-rich aryl environment.13 Fortunately, this complication could be avoided by performing the iodination without isolating the intermediate 11. Thus, reacting crude 11 with N-iodosuccinimide (NIS) in refluxing THF (4 days) gave the desired iodide 12 in 93% yield over the two steps from 5.14,15 Coupling of chromane-6-iodide 12 with 13 (1.2 equiv) at RT (44 h) under the conditions developed by Jackson et al. in their initial studies17 proved relatively uneventful and gave the desired 15 in 47% yield. Using a re-optimized procedure the chromane-6-iodide 12 was used in the palladium-catalyzed Negishi coupling with the serine-derived organozinc reagent 1316 together with SPhos (14) and Pd2dba3 as the Palladium source at room temperature resulting 75% yield of 15 and 70% yield from triflate 5. Also, the literature procedure was slightly modified by using 2 equiv. of 13 to improve coupling efficiency with the relatively valuable iodide 12, but the other variables were not changed.16 On the other hand, an attempt to use the same procedure starting from triflate 5 in place of the iodide gave only traces of 15 (<5%). The result was a 75% yield of 15 from iodide 1218, or 70% from triflate 5 as shown in Scheme 2.
Scheme 2.
Negishi coupling to amino acid derivatives
In summary, the desired conversion from triflate 5 to amino acid derivatives 9, 10, and 15 has been demonstrated. The sp2-sp2 Suzuki coupling between the boronate 6 and alkenyl bromide 7 is somewhat higher yielding compared to the sp3-sp2 Negishi coupling strategy (iodide 12 with 13), but either approach offers improved efficiency compared to the literature alternatives1–4 for analogous transformations. If the ultimate target is a protected amino ester, as represented by 15 in the current study, then either approach would involve three steps from the aryl triflate. The Suzuki coupling approach would require an enantioselective hydrogenation step11 to access the chiral amino ester, but the other stages explicitly demonstrated in this report involve simple chemistry and provide the easiest access to the desired carbon framework.
Supplementary Material
Acknowledgments
This work was supported in part by the Institute of General Medical Sciences, NIH (GM067146). I would also like to thank Professor Edwin Vedejs, Aleksandrs Prokofjevs, and Professor Robert Sammelson for their support and guidance.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References and notes
- 1.Rao AVR, Gurjar MK, Reddy AB, Khare VB. Tetrahedron Lett. 1993;34:1657. [Google Scholar]
- 2.Dexter CS, Jackson RFW, Elliott J. Tetrahedron. 2000;56:4539. [Google Scholar]
- 3.Yoshihara HAI, Apriletti JW, Baxter JD, Scanlan TS. J Med Chem. 2003;46:3152. doi: 10.1021/jm0301181. [DOI] [PubMed] [Google Scholar]
- 4.Davenport RJ, Ratcliffe AJ, Perry B, Phillips DJ, Jones MW, Demaude T, Knerr L. WO 2008064823 A1 20080605 PCT Int Appl. 2008
- 5.Salvatore BA, Mahdavian E, Eytina J, Landry G, Smink S. Tetrahedron Letters. 2009;50:19. [Google Scholar]
- 6.Reviews: Miyaura N, Suzuki A. Chem Rev. 1995;95:2458.Dembitsky VM, Abu AH, Srebnik M. Studies in Inorganic Chemistry. 2005;22:119.
- 7.Ishiyama T, Ishida K, Miyaura N. Tetrahedron. 2001;57:9813. [Google Scholar]
- 8.Olsen RK, Richards KD, Kolar AJ, Srinivasan A, Stephenson RW. J Org Chem. 1976;41:3674. [Google Scholar]
- 9.(a) Taylor RJK, Collier PN, Campbell AD, Patel I, Raynham TM. J Org Chem. 2002;67:1802. doi: 10.1021/jo010865a. [DOI] [PubMed] [Google Scholar]; (b) Queiroz MRP, Silva NO, Abreu AS, Ferreira PMT, Monteiro LS. Eur J Org Chem. 2002;15:2524. [Google Scholar]; (c) Singh J, Kronenthal DR, Schwindent M, et al. Org Lett. 2003;5:3155. doi: 10.1021/ol0352308. [DOI] [PubMed] [Google Scholar]
- 10.The E-isomer of 7 has also been reported (ref. 9b and subsequent publications by the same group), but the reported NMR spectrum appears to be identical to the data for the Z-isomer 7.
- 11.(a) N-Acetyl-dehydroamino acid hydrogenation: Minnaard AJ, Feringa BL, Lefort L, De Vries JG. Acc Chem Res. 2007;40:1267. doi: 10.1021/ar7001107.Xie JH, Zhou QL. Acc Chem Res. 2008;41:581. doi: 10.1021/ar700137z.N-Boc-dehydroamino acid hydrogenation: Kreuzfeld H-J, Döbler C, Krause HW, Facklam C. Tetrahedron: Asymmetry. 1993;4:2047.Ojima I, Yoda N, Yatabe M, Tanaka T, Kocure T. Tetrahedron. 1984;40:1255.
- 12.Scott WJ, Crisp GT, Stille JK. J Am Chem Soc. 1984;106:4630. [Google Scholar]
- 13.(a) Eaborn C, Pande KC. J Chem Soc. 1961:3715. [Google Scholar]; (b) Kozuka S, Naribayashi I, Nakagami J, Ogino K. Bull Chem Soc Jpn. 1980;53:438. [Google Scholar]; (c) Lo Fiego MJ, Lockhart MT, Chopa AB. J Organomet Chem. 2009;694:3674. [Google Scholar]
- 14.For analogous brominations, see Wulff WD, Rawat M, Prutyanov V. J Am Chem Soc. 2006;128:11044. doi: 10.1021/ja0568852. and references therein.
- 15.(a) For the direct conversion from 5 to the aryl bromide, see Shen X, Hyde AM, Buchwald SL. J Am Chem Soc. 2010;132:14076. doi: 10.1021/ja107481a.A method for converting electron poor aryl triflates into aryl iodides has been reported: Rohbogner CJ, Diene CR, Korn TJ, Knochel P. Angewandte Chem, Int Ed. 2010;49:1874. doi: 10.1002/anie.200905379.
- 16.(a) Ross AJ, Lang HL, Jackson RFW. J Org Chem. 2010;75:245. doi: 10.1021/jo902238n. [DOI] [PubMed] [Google Scholar]; (b) Goddard CML, Massah AR, Jackson RFW. Tetrahedron. 2010;66:9175. [Google Scholar]
- 17.Dumez E, Snaith JS, Jackson RFW, McElroy AB, Overington J, Wythes MJ, Withka JM, McLellan TJ. J Org Chem. 2002;67:4882. doi: 10.1021/jo025615o. [DOI] [PubMed] [Google Scholar]
- 18.Procedure: Catalyst Pd2dba3 (22 mg, 0.025 mmol) and SPhos ligand (14; 21 mg, 0.05 mmol) were added in one portion to the solution of organozinc reagent 13 followed by syringe addition of iodide 12 (384 mg, 0.75 mmol) in DMF (0.5 mL). The mixture was stirred at room temperature overnight under a positive pressure of nitrogen. The crude reaction mixture was applied directly to a silica gel column and purified by flash column chromatography (9: 1 hexanes: ethyl acetate), to provide 331 mg (75%) of 15
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.


